| ARCHETYPE ID | openEHR-EHR-OBSERVATION.iga_eczema_treat.v0 |
|---|---|
| Concept | IGA eczema (TREAT) |
| Description | Investigator global assessment (PGA) to describe the severity of their eczema for the treatment of severe atopic eczema trial (TREAT). |
| Use | A representative area should be chosen as a means to determine a patient's IGA. |
| Purpose | To record a clinical assessment of the severity of atopic dermatitis. This version is being used by the TREAT eczema group. |
| References | The treatment of severe atopic eczema trial (TREAT) trial. Available from: http://www.isrctn.com/ISRCTN15837754 |
| Copyright | © openEHR Foundation |
| Authors | Author name: Dmitri Wall Organisation: Irish Skin Foundation Email: dmitri.wall@gmail.com Date originally authored: 2015-02-05 |
| Other Details Language | Author name: Dmitri Wall Organisation: Irish Skin Foundation Email: dmitri.wall@gmail.com Date originally authored: 2015-02-05 |
| Other Details (Language Independent) |
|
| Keywords | Atopic Dermatitis, Dermatology, Effectiveness outcome parameter, Severity scale |
| Lifecycle | in_development |
| UID | c8e2f9e2-47d3-32da-b908-2478dd7e0e5e |
| Language used | en |
| Citeable Identifier | 1246.145.2560 |
| Revision Number | 0.0.1-alpha |
| protocol | |
| Extension | Extension: Additional information required to capture local content or to align with other reference models/formalisms. For example: local information requirements or additional metadata to align with FHIR or CIMI equivalents. Include: All not explicitly excluded archetypes |
| data | |
| Assessment score | Assessment score: The total IGA score. A representative area should be utilised as a means to generate this score. 0: Clear [No inflammatory signs of atopic dermatitis.] 1: Almost clear [Just perceptible erythema and just perceptible papulation/infiltration.] 2: Mild disease [Mild erythema and mild papulation/infiltration.] 3: Moderate disease [Moderate erythema and moderate papulation/infiltration.] 4: Severe disease [Severe erythema and severe papulation/infiltration.] 5: Very severe disease [Severe erythema and severe papulation/infiltration with oozing/crusting.] |
| events | |
| Any event | Any event: Any event. |
| Other contributors | Ian McNicoll, freshEHR Clinical Informatics, UK |
| Translators |